CVB homepage

cardiologist heart model doctor

“A drug that can both decrease the risk for diabetes along with the risk for having a heart attack or stroke could be a turning point in our ability to safely treat this growing population in the U.S. and abroad,” one researcher said.

fda medical device recall

In September, the FDA warned that certain Impella heart pump controllers may need hardware, firmware and/or software updates. The agency has now categorized the issue as a Class I recall. The devices should be removed from where they are used or sold until they can be serviced. 

cardiologist viewing heart data

Self-expanding valves, a history of stroke, renal dysfunction and nontransfemoral access were all linked to an increased risk of in-hospital stroke after TAVR. “Despite advances in valve design and technique, the overall stroke rate has plateaued,” researchers wrote.

These are regions where the Medicare Ambulatory Specialty Model (ASM) for heart failure will be implement starting Jan. 1, 2027. About 60% of the regions are rural and there are concerns the new mandatory participation model may cause cardiologists to not see heart failure patients. The ASM will reduce pay for most cardiologists and the they can be penalized with further cuts if a patient has a hospital admission, even it they were not immediately under the physician's care.

The Center for Healthcare Quality and Payment Reform believes many physicians participating in the new Ambulatory Specialty Model could end up experiencing a pay cut. In addition, it could drive some specialists to stop treating heart failure patients altogether.

Product Recall

Medtronic identified an issue with its CareLink SmartSync device manager providing inaccurate longevity estimates for certain leadless pacemakers. Customers can download a software update to resolve the issue going forward.

HFSA scientific statement on need to make Right Heart Failure (RHF) its own disease state separate from left HF.

The Heart Failure Society of America has shard a new scientific statement calling for right heart failure to be recognized as its own distinct clinical syndrome instead of a secondary complication of left-sided heart disease.

Innovation at work

Traditionally, the interventional cardiologist first visualizes the coronary anatomy in detail when contrast is injected in the catheterization laboratory. For many patients, however, that anatomy has already been captured, often in considerable detail, by coronary CT angiography (CCTA) performed earlier in the clinical pathway. This article considers how this dataset can be used to plan the procedure, an approach referred to as CT-guided PCI.

Sponsored by Philips Healthcare